Overview

This trial is active, not recruiting.

Condition interstitial lung disease
Sponsor Robert Tighe
Collaborator Durham VA Medical Center
Start date July 2016
End date November 2016
Trial size 3000 participants
Trial identifier NCT02479126, 01882

Summary

The primary objective of this research project is to describe the characteristics, diagnosis, management, and outcomes of patients with Interstitial Lung Disease (ILD) who received care at the Veteran's Administration Veterans Integrated Service Network (VISN) 6 Mid-Atlantic Health Care Network (VISN6) (includes North Carolina, Virginia and West Virginia) for up to 5 years.

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Observational model cohort
Time perspective retrospective
Arm
Patients will be identified from a specified 5 year period based on an International Classification of Diseases-9 (ICD-9) code diagnosis of Interstitial Lung disease (515) or Idiopathic Pulmonary Fibrosis (516.3). The patients will be obtained from the records of the Veterans Integrated Service Network (VISN) 6: VA Mid-Atlantic Health Care Network.

Primary Outcomes

Measure
Prevalence of Interstitial Lung Disease in the VISN6 Veterans Administration Patient Population
time frame: up to 5 years
Prevalence of Idiopathic Pulmonary Fibrosis in the VISN6 Veterans Administration Patient Population
time frame: up to 5 years

Secondary Outcomes

Measure
Accuracy of ICD-9 Codes for diagnosis of Interstitial Lung Disease
time frame: up to 5 years
Frequency of ICD-9 code diagnosis of Interstitial Lung Disease and clinic consultation with a pulmonary provider
time frame: up to 5 years
Prevalence of Co-morbid Diabetes Mellitus with Interstitial Lung Disease
time frame: up to five years

Eligibility Criteria

Male or female participants at least 18 years old.

Inclusion Criteria: - Interstitial Lung Disease (ILD) ICD-9 code diagnosis 515.0 or 516.3 Exclusion Criteria: - Inadequate documentation of patient receiving care for ILD in the health records

Additional Information

Official title Interstitial Lung Diseases in the Veterans Administration Health System - A Retrospective Description of Patient Characteristics, Management, and Outcomes
Principal investigator Robert M Tighe, MD
Trial information was received from ClinicalTrials.gov and was last updated in August 2016.
Information provided to ClinicalTrials.gov by Durham VA Medical Center.